These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9809940)

  • 1. Health outcomes associated with beta-blocker and diltiazem treatment of unstable angina.
    Smith NL; Reiber GE; Psaty BM; Heckbert SR; Siscovick DS; Ritchie JL; Every NR; Koepsell TD
    J Am Coll Cardiol; 1998 Nov; 32(5):1305-11. PubMed ID: 9809940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the post-hospitalization medical treatment of unstable angina pectoris: 1990 to 1995.
    Smith NL; Reiber GE; Psaty BM; Heckbert SR; Siscovick DS; Ritchie JL; Every NR; Koepsell TD
    Am J Cardiol; 1999 Sep; 84(6):632-8. PubMed ID: 10498130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up after early intervention with intravenous diltiazem or intravenous nitroglycerin for unstable angina pectoris.
    Göbel EJ; van Gilst WH; de Kam PJ; ter Napel MG; Molhoek GP; Lie KI
    Eur Heart J; 1998 Aug; 19(8):1208-13. PubMed ID: 9740342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A multicenter, randomized clinical trial of intravenous diltiazem in treatment of unstable angina].
    Collaborative Group of Diltiazem
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Mar; 33(3):238-42. PubMed ID: 15929820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects.
    Strauss WE; Parisi AF
    Ann Intern Med; 1988 Oct; 109(7):570-81. PubMed ID: 2901816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
    Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
    JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonists in the treatment of Prinzmetal's angina and unstable angina pectoris.
    Beller GA
    Circulation; 1989 Dec; 80(6 Suppl):IV78-87. PubMed ID: 2574642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris.
    Bress AP; Dodson JA; King JB; Sauer BC; Reese T; Crook J; Radwanski P; Knippenberg K; Greene T; Nelson RE; Munger MA; Weintraub WS; LaFleur J
    Am J Cardiol; 2018 Dec; 122(11):1809-1816. PubMed ID: 30292334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
    Van Der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Br J Clin Pharmacol; 1999 May; 47(5):493-8. PubMed ID: 10336572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators.
    Knight CJ; Fox KM
    Am J Cardiol; 1998 Jan; 81(2):133-6. PubMed ID: 9591893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
    Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
    J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac conduction with diltiazem and beta-blockade combined. A review and report on cases.
    Kjeldsen SE; Syvertsen JO; Hedner T
    Blood Press; 1996 Sep; 5(5):260-3. PubMed ID: 8879597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study comparing propranolol and diltiazem in the treatment of unstable angina.
    Théroux P; Taeymans Y; Morissette D; Bosch X; Pelletier GB; Waters DD
    J Am Coll Cardiol; 1985 Mar; 5(3):717-22. PubMed ID: 3882812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome with calcium channel antagonists after myocardial infarction: a community-based study.
    Leitch JW; McElduff P; Dobson A; Heller R
    J Am Coll Cardiol; 1998 Jan; 31(1):111-7. PubMed ID: 9426027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
    Soumerai SB; McLaughlin TJ; Spiegelman D; Hertzmark E; Thibault G; Goldman L
    JAMA; 1997 Jan; 277(2):115-21. PubMed ID: 8990335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.